Because expansion of β cell mass is a critical component of islet adaptation to insulin resistance and the maintenance of glucose homeostasis, methods to promote β cell growth and proliferation offer invaluable therapeutic tools for T2D. The gene discussed is INS; the disease is type 2 diabetes mellitus.